BenevolentAI Investor Presentation Deck
Drug development is failing patients
$160bn+
spent per year
on drug R&D
Expensive & high risk
OS- Overall Survival
$2.6bn
in average R&D
and to market
cost per drug
The underlying mechanisms of
complex multifactorial diseases
are often misunderstood
96%
overall failure
rate in drug
development
Long R&D cycles
10 years
to market
9,000
diseases with no
effective
treatment
Poor efficacy &
high societal cost
The human body is an incredibly
complex information system made
up of over 37 trillion cells
Leading drugs
effective on
30-50%
of patients
Approved cancer
drugs have poor
response rates,
with only
7%
A key reason for failure in drug development is the lack of understanding of the
underlying biology
showing an OS
advantage
Scientists can't keep up with
exponential growth of biomedical
research and data - 2,314 exabytes
of healthcare data generated last
year alone
Benevolent
3View entire presentation